Epirubicin
Top View
- Large-Scale Drug Screening in Patient-Derived IDH Glioma Stem
- DRUG NAME: Fluorouracil
- Comparison of Three Different Chemotherapy Regimens Containing Epirubicin in Hormone- Refractory Prostate Cancer Patients
- Esophageal and Esophagogastric Junction
- Feasibility of 21-Day Continuous Infusion of Epirubicin in Hormone-Refractory Prostate Cancer Patients
- Systemic Therapy for Limited Stage Small Cell Lung Carcinoma
- Epirubicin and Vinorelbine
- Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Anthracycline‑Induced Cardiotoxicity in the Chemotherapy Treatment of Breast Cancer: Preventive Strategies and Treatment (Review)
- Cisplatin Epirubicin Fluorouracil (ECF)
- Chemogenomic Screening Identifies the Hsp70 Co-Chaperone HDJ2 As
- Epirubicin–Vinorelbine Vs FEC100 for Node-Positive, Early Breast Cancer: French Adjuvant Study Group 09 Trial
- Epirubicin Fluorouracil Oxaliplatin (EOF)
- Emetogenic Potential of Antineoplastic Agents
- Epirubicin and Cyclophosphamide) (Breast)
- Sequential Docetaxel Followed by Epirubicin-Vinorelbine As First-Line Chemotherapy in Advanced Breast Cancer
- Epirubicin Hydrochloride for Injection